Validation of AI-based Information Systems for Sensitive Use Cases: Using an XAI Approach in Pharmaceutical Engineering

4 Jan, 2022 | Publications

Artificial Intelligence (AI) is adopted in many businesses. However, adoption lacks behind for use cases with regulatory or compliance requirements, as validation and auditing of AI is still unresolved. AI’s opaqueness (i.e., “black box”) makes the validation challenging for auditors.

Explainable AI (XAI) is the proposed technical countermeasure that can support validation and auditing of AI. We developed an XAI based validation approach for AI in sensitive use cases that facilitates the understanding of the system’s behaviour. We conducted a case study in pharmaceutical manufacturing where strict regulatory requirements are present. The validation approach and an XAI prototype were developed through multiple workshops and was then tested and evaluated with interviews.

Our approach proved suitable to collect the required evidence for a software validation, but requires additional efforts compared to a traditional software validation. AI validation is an iterative process and clear regulations and guidelines are needed.

View the full article in the journal and see how IKOSA supported the research


Join our newsletter